Topic

New Jersey

A collection of 505 issues

Abecma (Idecabtagene Vicleucel) Approval with Blue Cross Blue Shield in New Jersey: Complete Coverage Guide

Answer Box: Getting Abecma Covered in New Jersey Eligibility: Adults with relapsed/refractory multiple myeloma after ≥2 prior lines including an IMiD, proteasome inhibitor, and anti-CD38 antibody. Fastest path: Your oncologist submits prior authorization to Horizon Blue Cross Blue Shield through Prime Therapeutics, including complete treatment history and medical necessity
7 min read

How to Get Palynziq Approved by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Palynziq Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Palynziq (pegvaliase-pqpz) with specific criteria: confirmed PKU diagnosis, blood phenylalanine >600 µmol/L, failed sapropterin trial, and REMS enrollment. Submit through the UnitedHealthcare provider portal with complete clinical documentation. If denied, you have 180
6 min read

How to Get Defitelio (defibrotide) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Defitelio Covered by Aetna CVS Health in New Jersey Defitelio requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD) with organ dysfunction following stem cell transplant. Your transplant team must submit clinical documentation proving VOD diagnosis using Baltimore or Cairo criteria, plus evidence of
5 min read

How to Get Uplizna (Inebilizumab) Covered by UnitedHealthcare in New Jersey: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Uplizna Covered by UnitedHealthcare in New Jersey Uplizna (inebilizumab) requires prior authorization from UnitedHealthcare for both NMOSD and IgG4-related disease. Submit through the UnitedHealthcare Provider Portal with specialist documentation, AQP4-IgG test results, and prior treatment history. If denied, you have 180 days to appeal internally, then can
5 min read

Humana's Coverage Criteria for Onivyde (Irinotecan Liposome) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Humana Onivyde Coverage in New Jersey Onivyde (irinotecan liposome) is covered by Humana Medicare Advantage with prior authorization for FDA-approved pancreatic cancer indications. Medical necessity requires: ECOG performance status 0-1, documented diagnosis, and appropriate line of therapy (first-line NALIRIFOX or second-line post-gemcitabine). Fastest approval: Submit complete PA documentation
5 min read

Work With Your Doctor to Get Haegarda Covered by UnitedHealthcare in New Jersey: Provider Partnership Guide

Answer Box: Getting Haegarda Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Haegarda (C1-esterase inhibitor, SC) with strict documentation requirements. Success depends on partnering with an immunologist or allergist who can demonstrate confirmed HAE diagnosis, attack frequency justifying prophylaxis, and failure of preferred alternatives. In New Jersey,
6 min read